Sat, Sep 20, 2014, 5:01 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Rockwell Medical, Inc. Message Board

renalman55 14 posts  |  Last Activity: Aug 25, 2014 11:49 PM Member since: Jan 3, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • renalman55 by renalman55 Aug 25, 2014 11:49 PM Flag

    In less than five months we will know whether or not Tirferic gets FDA approval .. In my mind it is a no brainer..14 years of research and 150 million spent on animal and human trials and thousands of adverse less EPO required...nothing but positive outcomes...Less expensive and easier to administer... Much less, if any toxic Iron IV injections needed...Patients in Phase 2 and 3 studies are raving about how much better they feel when using Triferic in dialysis...guidance for these studies came from RMTI working closely with and listening to the FDA...this is a winner... the Safety profile of Triferic is outstanding...the FDA like drugs that are safe and effective and affordable for all patients...together with Calcitrol and Citrapure, Triferic makes this a homerun in future Medicare bundling...Medicare and the FDA like to save money!!...Which product would you want to be on??...the same old toxic and expensive ones that make you feel like #$%$ OR Triferic which is safe and effective and makes you feel normal again...If you were a dialysis provider or physician which one would you want your patients on...the same old same old drugs that are toxic and can cause complications OR Triferic which is proven to help patients and makes the whole dialysis process safer and more effective which no ugly lawsuits from toxic drugs???

    Calcitrol and Citrapure sales will soon add to the bottom line and there will be plenty of funding going forward.

    One has to wonder why any normal investor, who has done their Due Diligence, would not be buying this stock with both hands at these prices!! To sell is short is really stupid...this puppy will not be kept down much longer...I have a feeling that management has had enough of this questionable manipulation...a good "poke in the eye with a sharp stick" is coming soon for these clowns and they deserve it!!!!

    Absolutely a STRONG BUY and the clock is ticking -- less than 5 months!

    Sentiment: Strong Buy

  • Reply to

    Close below $10 is extremely bearish......???

    by hymanroz Aug 21, 2014 4:52 PM
    renalman55 renalman55 Aug 23, 2014 2:39 PM Flag

    They have plenty of money.

    Obviously ProThink (whoever they are??) knows nothing about Triferic and Rockwell. The FDA has been working closely with Rockwell on getting Triferic approved. Much less expensive and along with Calcitrol and Citrapure. it is very attractive to the FDA for bundling in 2015. Plus it is SAFE and effective and the patient feels better!!

    Calcitrol, now that it is approved, will really begin to bring in revenue for RMTI.

    You are short and full of lies about RMTI. Get a life.

    Sentiment: Strong Buy

  • Reply to

    Close below $10 is extremely bearish......???

    by hymanroz Aug 21, 2014 4:52 PM
    renalman55 renalman55 Aug 22, 2014 3:22 PM Flag

    We will see.

    Sentiment: Strong Buy

  • Reply to

    Will they need to do another offering or

    by tradingwithyourhead Aug 21, 2014 12:53 PM
    renalman55 renalman55 Aug 21, 2014 1:20 PM Flag


    Sentiment: Strong Buy

  • renalman55 renalman55 Aug 15, 2014 8:59 AM Flag

    One hatchet job by Brean is unacceptable, two hatchet jobs is totally unacceptable. RMTI and its attorneys and the many institutions that are on board should be outraged at this. The average investor should not have to put up with this BS.

    RMTI is targeted and maybe this is a good thing. The Wall Street cronies are concerned.

    I see a big pop coming today as this price is a bargain!

    Sentiment: Strong Buy

  • Reply to

    Getting Ready to Harvest

    by renalman55 Aug 2, 2014 9:45 PM
    renalman55 renalman55 Aug 9, 2014 10:30 PM Flag

    Rockwell has been working closely with the FDA on this 14 year and 150 million dollar approval process. There has not been one negative that I know of. Triferic is safe and effective.

    It is hard for me to believe that the FDA would turn it down as they have made recommendations to Rockwell concerning Triferic. Plus SFP was allowed to receive the name Triferic by the FDA before approval. A good sign indeed.

    125 institutions thinks so also. They have done their Due Diligence,

    Sentiment: Strong Buy

  • Reply to

    Getting Ready to Harvest

    by renalman55 Aug 2, 2014 9:45 PM
    renalman55 renalman55 Aug 3, 2014 8:31 AM Flag

    The "Wild Card" that no one seems to be paying attention to is a partnership and/or licensing agreement(s). This will happen - probably sooner than later.

    A big player has plenty of cash.

    Sentiment: Strong Buy

  • Rockwell is progressing well:

    They have enough money in reserve to bring Calcitrol and Triferic to market.

    Calcitrol will add a minimum of 50 million to the bottom line. Every quarter from here and on will continue to improve.

    Calcitrol will be the Vitamin D drug of choice for Davita Clinics as Rockwell has a 5 year dialysis supply contract for Citrapure. Citrapure is also becoming the dialysate of choice by most dialysis centers.

    Rockwell continues to work closely with the FDA as Triferic data is analyzed.

    Triferic is safe and effective and leading nephrologists have given Triferic their blessing.

    Triferic is much less expensive to administer than anything in the pipeline. Presently, any physician owned dialysis center is having difficulty making ends make due to Medicare's low reimbursement rate. Triferic is much less expensive and with bundling and less EPO and Iron IV required, Medicare costs will drop and these privately owned dialysis centers will finally be able to make some money. The patients feel better, Medicare spends less and all dialysis centers make money.

    Rockwell continues to work with potential partners and licensing possibilities. Something big could "pop" at any time.

    In less than six months we will all find out if Triferic is granted approval. After 14 years and 150 million spent and many hurdles jumped Triferic will corner the dialysis market once approved. It will make bundling affordable for all players.

    It would not surprise me if the FDA approves Triferic earlier than Jan. 24, 2015. It is up to them. They can rule at anytime. Especially in light of Triferic's wonderful safety profile. Safe is preferred!!

    Shorts are beginning to cover. They are beginning to see that Rockwell and Triferic and Citrapure and Calcitrol will all be around for a long time.

    The "Harvest" is beginning to shape up. Shares are more difficult to buy as owners are holding for the many good things to come. Don't let the door hit you in the "ars"!! Buy now!!

    Sentiment: Strong Buy

  • In less than 6 months (January 24th) we will all find out from the FDA if Triferic is approved. 14 years of research and studies and 150 million spent will all be answered.

    Triferic has clearly demonstrated that it is a safe, effective and less expensive way of getting very ill dialysis patients the iron they need -- with no toxic side effects.

    Plus Rockwell has been working closely with the FDA and following their recommendations.

    Kind of a "no brainer" don't you think??!! Obviously, most institutions and share holders are sitting on the sidelines anticipating this day -- based on the daily low volume of shares traded. To buy and sell now seems kind of ridiculous considering the 40% Federal and State taxes you will have to pay on any profits, if you buy and sell before 1 year is up.

    If one continues to buy and sell for pennies you had better keep great records of your gains on each transaction or you will be in a world of hurt at tax time!!

    Sentiment: Strong Buy

  • renalman55 renalman55 Jul 10, 2014 6:53 PM Flag

    I purchased several thousand shares at under 1.00 per share in 2001. They were administering SFP now called Triferic successfully and safely to animals at the time.

    We are now, 13 years later, right where we want to be -- awaiting approval of a brand new, safe, effective and cost saving drug that will improve the quality of life for most dialysis patients.

    Sentiment: Strong Buy

  • renalman55 renalman55 Jul 10, 2014 1:09 PM Flag

    I personally know of a patient that felt so much better on Triferic during Phase 3 . He could finally carry on normal daily activities without feeling like #$%$.

    This stock is being manipulated and with reason. Someone or a hedge fund wants it low so they can accumulate shares and score big in the end. They make money now shorting and they make it in the end. Hopefully, they get their #$%$ burned in a big way. At any moment there could be a partnership or a buy-out announced.

    Everything positive moves the stock lower?? We have not had one negative event!! The safety profile is wonderful. It does not add up.

    Maybe a company connected to dialysis or a fund that could lose big is somehow manipulating the stock price?? It is strange to say the least.

    125 institutions are invested and believe in Triferic and Rockwell. I guess we will find out on or before Jan. 24th. Patience is a virtue in this situation. If you panic you lose and that is what this monster wants you to do.

    Sentiment: Strong Buy

  • Reply to

    Market is 16,900

    by aussieaye Jul 8, 2014 5:50 PM
    renalman55 renalman55 Jul 9, 2014 7:20 PM Flag

    These sellers are the same old manipulators. There is nothing negative to know.

    Everything is in place. Calcitrol is fully approved. Core business is solid. Triferic is in the hands of the FDA for approval on or before Jan. 24th.

    In my opinion what is going on is illegal manipulation of a stock that should be 20.00/share!! There is a pattern and it has been going on for a very long time.

    Hopefully, a partnership, licensing agreement or buy-out is announced soon and we can eliminate these manipulators for good!!

    Sentiment: Strong Buy

  • Reply to

    The Future....After Triferic

    by mjacob56 Jul 3, 2014 7:04 PM
    renalman55 renalman55 Jul 4, 2014 9:03 AM Flag

    "All our eggs in one basket" is a ridiculous statement"! Obviously you have not followed Rockwell OR you are a squirming short.

    If Triferic is approved the PPS will be $100.00 per share. Triferic will absolutely change the way dialysis is performed and lower the cost significantly. EPO use will drop 35%, toxic Iron IV injections will be a thing of the past. (I wonder how Amgen will feel about losing 1 billion in EPO sales. PLUS Triferic has a SAFE profile with no adverse reactions or deaths -- not many drugs can say that. The FDA likes safe drugs!!!!

    Triferic may have several other applications. Such as iron maintenance for women or patients with severe anemia. The sky is the limit! Iron supplements for the general population, etc.

    Rockwell has a very successful core business and not just one product like so many companies. You need to do some due diligence before you make stupid statements that hedge to the short side.

    Patients that have been on Triferic cannot believe how much better they feel. To the point of feeling normal again -- without the toxicity of Iron IV injections! The upside of Triferic is mind boggling.

    The PPS will sky rocket as we approach January 24th and the FDA's decision on the approval of Triferic.. Less than 7 months away!!

    Sentiment: Strong Buy

  • renalman55 by renalman55 Jun 23, 2014 8:48 AM Flag

    Great news. Calcitrol approved. Bottom line increases significantly. Plenty of money in the bank. Rockwell now becomes a very attractive partner or buy-out possibility. Nothing negative with the FDA going forward to January 24, 2015 when Triferic should be approved. A huge short squeeze is brewing. This approval was not priced into PPS. Those that think so are Shorts whose level of concern is rising big time!!

    Buy now or just wave to us in the rear view mirror!!!

    Sentiment: Strong Buy

9.76-0.19(-1.91%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.